Skip to main content
. 2015 Apr 22;25(4):593–598. doi: 10.1097/IGC.0000000000000415

FIGURE 1.

FIGURE 1

Kaplan-Meier survival curves of patients with ovarian cancer according to pretreatment plasma DD levels. Prognosis is significantly poorer for patients with DD ≥ 2.0 μg/mL (n = 96) than patients with DD < 2.0 μg/mL (n = 38; P = 0.039).